Moras D - Search Results

1

Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12.

Lupien M, Jeyakumar M, Hébert E, Hilmi K, Cotnoir-White D, Loch C, Auger A, Dayan G, Pinard GA, Wurtz JM, Moras D, Katzenellenbogen J, Mader S. Lupien M, et al. Among authors: moras d. Mol Endocrinol. 2007 Apr;21(4):797-816. doi: 10.1210/me.2006-0074. Epub 2007 Feb 13. Mol Endocrinol. 2007. PMID: 17299137

2

Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3.

Greschik H, Wurtz JM, Sanglier S, Bourguet W, van Dorsselaer A, Moras D, Renaud JP. Greschik H, et al. Among authors: moras d. Mol Cell. 2002 Feb;9(2):303-13. doi: 10.1016/s1097-2765(02)00444-6. Mol Cell. 2002. PMID: 11864604 Free article.

3

A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita.

Lalli E, Bardoni B, Zazopoulos E, Wurtz JM, Strom TM, Moras D, Sassone-Corsi P. Lalli E, et al. Among authors: moras d. Mol Endocrinol. 1997 Dec;11(13):1950-60. doi: 10.1210/mend.11.13.0038. Mol Endocrinol. 1997. PMID: 9415399

4

Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor.

Hellal-Levy C, Fagart J, Souque A, Wurtz JM, Moras D, Rafestin-Oblin ME. Hellal-Levy C, et al. Among authors: moras d. Mol Endocrinol. 2000 Aug;14(8):1210-21. doi: 10.1210/mend.14.8.0502. Mol Endocrinol. 2000. PMID: 10935545

5

Estrogen receptor transcription and transactivation: Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors.

Ruff M, Gangloff M, Wurtz JM, Moras D. Ruff M, et al. Among authors: moras d. Breast Cancer Res. 2000;2(5):353-9. doi: 10.1186/bcr80. Epub 2000 Jul 7. Breast Cancer Res. 2000. PMID: 11250728 Free PMC article. Review.

6

The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.

Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D. Rochel N, et al. Among authors: moras d. Mol Cell. 2000 Jan;5(1):173-9. doi: 10.1016/s1097-2765(00)80413-x. Mol Cell. 2000. PMID: 10678179 Free article.

7

Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity.

Robin-Jagerschmidt C, Wurtz JM, Guillot B, Gofflo D, Benhamou B, Vergezac A, Ossart C, Moras D, Philibert D. Robin-Jagerschmidt C, et al. Among authors: moras d. Mol Endocrinol. 2000 Jul;14(7):1028-37. doi: 10.1210/mend.14.7.0484. Mol Endocrinol. 2000. PMID: 10894152

8

Ligand selectivity by nuclear hormone receptors.

Wurtz JM, Moras D. Wurtz JM, et al. Among authors: moras d. J Biomol Struct Dyn. 2000;17 Suppl 1:17-21. doi: 10.1080/07391102.2000.10506599. J Biomol Struct Dyn. 2000. PMID: 22607402

9

Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.

Wurtz JM, Egner U, Heinrich N, Moras D, Mueller-Fahrnow A. Wurtz JM, et al. Among authors: moras d. J Med Chem. 1998 May 21;41(11):1803-14. doi: 10.1021/jm970406v. J Med Chem. 1998. PMID: 9599231

10

Molecular determinants for agonist and antagonist binding to steroid nuclear receptors.

Wurtz JM, Moras D. Wurtz JM, et al. Among authors: moras d. Ernst Schering Res Found Workshop. 2001;(34):167-80. doi: 10.1007/978-3-662-04645-6_9. Ernst Schering Res Found Workshop. 2001. PMID: 11394044 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters